The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Endocrine Treatment of Transsexual People: A Review of Treatment Regimens, Outcomes, and Adverse Effects
Abstract
Cross-sex hormone treatment is an important component in medical treatment of transsexual people. Endocrinologists are often faced with designing treatment recommendations. Although guidelines from organizations, such as the Harry Benjamin International Gender Dysphoria Association, have been helpful, management remains complex and experience guided. We discuss the range of treatment used by transsexual people, the rationale behind these, and the expectation from such treatment. Recommendations from seven clinical research centers treating transsexual people are discussed. In addition, self-reported hormonal regimens from 25 male-to-female transsexual people and five female-to-male transsexual people are reported. Finally, the potential adverse effects of cross-sex hormone treatment of transsexual people are reviewed. In light of the complexity of managing treatment goals and adverse effects, the active involvement of a medical doctor experienced in cross-sex hormonal therapy is vital to ensure the safety of transsexual people.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Mortality and morbidity in transsexual subjects treated with cross‐sex hormones
Van Kesteren, P. J. M., Asscheman, H., Megens, J. A. J., & Gooren, L. J. G. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.2601068.x · Cited by 533
Oral Contraceptives and Cardiovascular Disease
Stadel, B. V. (1981) · New England Journal of Medicine · doi:10.1056/nejm198109103051104 · Cited by 494
Induction of insulin resistance by androgens and estrogens
Polderman, K. H. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.1.265 · Cited by 380
Treatment of Male Hypogonadism with Testosterone Enanthate*
SNYDER, P. J., & LAWRENCE, D. A. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-51-6-1335 · Cited by 296
The use and misuse of androgens
Wilson, J. D., & Griffin, J. E. (1980) · Metabolism · doi:10.1016/0026-0495(80)90159-6 · Cited by 257
Giltay, E. J., & Gooren, L. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.8.2913 · Cited by 230
Mortality and morbidity in transsexual patients with cross-gender hormone treatment
Asscheman, H., Gooren, L. J. G., & Eklund, P. L. E. (1989) · Metabolism · doi:10.1016/0026-0495(89)90233-3 · Cited by 219
Long-Term Testosterone Administration Increases Visceral Fat in Female to Male Transsexuals1
Elbers, J. M. H., Asscheman, H., Seidell, J. C., Megens, J. A. J., & Gooren, L. J. G. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.7.4078 · Cited by 213
Some aspects of the interaction between natural and synthetic female sex hormones and the liver
Adlercreutz, H., & Tenhunen, R. (1970) · The American Journal of Medicine · doi:10.1016/s0002-9343(70)80130-9 · Cited by 198
Prevalence of Transsexualism in the Netherlands
Eklund, P. L. E., Gooren, L. J. G., & Bezemer, P. D. (1988) · British Journal of Psychiatry · doi:10.1192/bjp.152.5.638 · Cited by 192
Histopathological Effects of Exogenously Administered Testosterone in 19 Female to Male Transsexuals
FUTTERWEIT, W., & DELIGDISCH, L. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-1-16 · Cited by 192
Elbers, J. M. H. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.10.3267 · Cited by 189
Meikle, A. W. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.74.3.623 · Cited by 185
Pubertal delay as an aid in diagnosis and treatment of a transsexual adolescent
Cohen-Kettenis, P. T., & van Goozen, S. H. M. (1998) · European Child & Adolescent Psychiatry · doi:10.1007/s007870050073 · Cited by 167
Physical and hormonal evaluation of transsexual patients: A longitudinal study
Meyer, W. J., Webb, A., Stuart, C. A., Finkelstein, J. W., Lawrence, B. L., & Walker, P. A. (1986) · Archives of Sexual Behavior · doi:10.1007/bf01542220 · Cited by 156
Hannaford, P. C., Croft, P. R., & Kay, C. R. (1994) · Stroke · doi:10.1161/01.str.25.5.935 · Cited by 148
Hormonal Effects of Soy in Premenopausal Women and Men
Kurzer, M. S. (2002) · Journal of Nutrition · doi:10.1093/jn/132.3.570s · Cited by 146
Estrogen-Induced Prolactinoma in a Man
Gooren, L. J., Assies, J., Asscheman, H., Slegte, R. G. M. D., & van Kessel, H. I. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-2-444 · Cited by 136
A psycho-endocrinological overview of transsexualism
Michel, A., Mormont, C., & Legros, J.-J. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1450365 · Cited by 120
SPECIAL ARTICLE Androgens: Risks and Benefits
Bardin, C. W., Swerdloff, R. S., & Santen, R. J. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-1-4 · Cited by 119
Mortality among oral contraceptive users
Porter, J., Jick, H., & Walker, A. M. (1988) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(88)90318-9 · Cited by 115
Prior, J. C., Vigna, Y. M., & Watson, D. B. (1989) · Archives of Sexual Behavior · doi:10.1007/bf01579291 · Cited by 109
Breast Cancer in a Male-to-Female Transsexual: A Case Report
Pritchard, T. J. (1988) · JAMA · doi:10.1001/jama.259.15.2278 · Cited by 108
Endocrine Therapy of Transsexualism and Potential Complications of Long-Term Treatment
Futterweit, W. (1998) · Archives of Sexual Behavior · doi:10.1023/a:1018638715498 · Cited by 97
PROLACTIN LEVELS AND PITUITARY ENLARGEMENT IN HORMONE-TREATED MALE-TO-FEMALE TRANSSEXUALS
Asscheman, H., Gooren, L. J., Assies, J., SMITS, J. P. H., & Slegte, R. G. M. D. (1988) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1988.tb03849.x · Cited by 95
van Kesteren, P. J. M., Lips, P. T. A. M., Devillé, W. L. J. M., Popp‐Snijders, C., Asscheman, H., Megens, J. A. J., & Gooren, L. J. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.6.8964856 · Cited by 95
Polycystic ovaries are a common finding in untreated female to male transsexuals
Balen, A. H., Schachter, M. E., Montgomery, D., Reid, R., & Jacobs, H. S. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb01013.x · Cited by 77
Single-dose pharmacokinetics of sublingual versus oral administration of micronized 17-estradiol
Price, T. M., Blauer, K. L., HANSEN, M., Stanczyk, F. Z., Lobo, R., & BATES, G. (1997) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(96)00513-3 · Cited by 76
Metastatic prostatic carcinoma in a male‐to‐female transsexual
Haarst, V., Newling, Gooren, Asscheman, & Prenger (1998) · British Journal of Urology · doi:10.1046/j.1464-410x.1998.00582.x · Cited by 70
Schlatterer, K., Yassouridis, A., von Werder, K., Poland, D., Kemper, J., & Stalla, G. K. (1998) · Archives of Sexual Behavior · doi:10.1023/a:1018704630036 · Cited by 64
Breast Augmentation: Compression—A Very Important Factor in Preventing Capsular Contracture
Camirand, A., Doucet, J., Harris, J., & Burkhardt, B. R. (1999) · Plastic & Reconstructive Surgery · doi:10.1097/00006534-199908000-00039 · Cited by 58
The impact of long-term testosterone replacement therapy on lipid and lipoprotein profiles in women
Goh, H. H., Loke, D. F. M., & Ratnam, S. S. (1995) · Maturitas · doi:10.1016/0378-5122(94)00861-z · Cited by 53
Sex Steroids, Insulin, and Arterial Stiffness in Women and Men
Giltay, E. J., Lambert, J., Gooren, L. J., Elbers, J. M. H., Steyn, M., & Stehouwer, C. D. A. (1999) · Hypertension · doi:10.1161/01.hyp.34.4.590 · Cited by 47
Giltay, E. J., Gooren, L. J., EMEIS, J. J., Kooistra, T., & Stehouwer, C. D. A. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.5.1396 · Cited by 45
Goh, H. H. V., & Ratnam, S. S. (1997) · Maturitas · doi:10.1016/s0378-5122(96)01073-0 · Cited by 41
Spinder, T., Spijkstra, J. J., Gooren, L. J., Hompes, P. G. A., & van Kessel, H. I. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-68-1-200 · Cited by 40
The role of androgens in the treatment of hematologic disorders.
Ammus, S. S. (1989) · PubMed · Cited by 24
Cited by
Coleman, E., Bockting, W., Botzer, M., Cohen-Kettenis, P., DeCuypere, G., Feldman, J., Fraser, L., Green, J., Knudson, G., Meyer, W. J., et al. (2012) · International Journal of Transgenderism · doi:10.1080/15532739.2011.700873 · Cited by 3,143
(2012) · Choice Reviews Online · doi:10.5860/choice.49-2699 · Cited by 2,593
Hembree, W. C., Cohen-Kettenis, P. T., Gooren, L., Hannema, S. E., Meyer, W. J., Murad, M. H., Rosenthal, S. M., Safer, J. D., Tangpricha, V., & T’Sjoen, G. G. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01658 · Cited by 2,328
“Spironolactone works by directly blocking androgens during their interaction with the androgen receptor (114, 133, 142).”
InfluentialEndocrine Treatment of Transsexual Persons:An Endocrine Society Clinical Practice Guideline
Hembree, W. C., Cohen-Kettenis, P., Delemarre-van de Waal, H. A., Gooren, L. J., Meyer, W. J., Spack, N. P., Tangpricha, V., & Montori, V. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0345 · Cited by 1,026
Sanchez, N. F., Sanchez, J. P., & Danoff, A. (2009) · American Journal of Public Health · doi:10.2105/ajph.2007.132035 · Cited by 418
Metadata
- Authors
- Moore, E., Wisniewski, A., & Dobs, A.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-08
- Volume
- 88
- Issue
- 8
- Pages
- 3467-3473
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2077474440
- Cited by
- 288
- References
- 38
- FWCI
- 10.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.